​
​

Augmedix Stock (NASDAQ:AUGX)

ForecastRevenueOwnershipFinancialsChartTranscripts
Augmedix by TradingView

Previous Close

$2.35

52W Range

$0.73 - $6.25

50D Avg

$2.30

200D Avg

$2.87

Market Cap

$116.16M

Avg Vol (3M)

$808.77K

Beta

-0.19

Div Yield

-

AUGX Company Profile

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,430

IPO Date

Mar 31, 2021

Website

AUGX Performance

AUGX Financial Summary

Dec 23Dec 22Dec 21
Revenue$44.85M$30.93M$22.16M
Operating Income$-18.78M$-22.37M$-17.94M
Net Income$-19.17M$-26.53M$-17.16M
EBITDA$-17.68M$-22.37M$-17.94M
Basic EPS$-0.44$-0.71$-0.59
Diluted EPS$-0.44$-0.71$-0.59

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q1 24May 13, 24 | 12:00 AM
Q4 23Mar 18, 24 | 11:05 PM
Q3 23Nov 06, 23 | 10:51 PM

Peer Comparison

TickerCompany
ACONAclarion, Inc.
DRMADermata Therapeutics, Inc.
UTRSMinerva Surgical, Inc.
INABIN8bio, Inc.
ELEVElevation Oncology, Inc.